Hemorrhagic Pleural Effusion - Pulmonology Advisor
Nov 15, 2023 · Hemorrhagic pleural effusion is considered an exudative pleural effusion. Exudative effusions occur when blood or lymph vessels are blocked due to inflammation, infection, lung injury, or tumors. 3 Hemorrhagic pleural effusion is defined as an erythrocyte count greater than 100,000 cells/µl. 2. Symptoms vary based on the underlying disease and ...
Diagnosis & Disease Information - Pulmonology Advisor
Thoracentesis. Thoracentesis, also known as a pleural tap, is a minimally invasive procedure performed to remove fluid or air from the pleural space surrounding the lungs. Thoracentesis is used to obtain a fluid sample for diagnosing and/or treating various health conditions, including pleural effusions, cancer, and pneumothoraces.
GINA 2024 Asthma Update: Revised Recommendations on …
Jun 28, 2024 · The GINA 2024 asthma update includes new guidance on medications, monitoring, treatment goals, remission, cough variant asthma, children, and more.
Trelegy Ellipta Improves Lung Function in Patients With …
May 7, 2019 · While not considered statistically significant, Trelegy Ellipta (100/62.5/25mcg and 200/62.5/25mcg) was associated with a 13% reduction in asthma exacerbations when compared with Breo Ellipta (100/25mcg and 200/25mcg). In addition, the study investigated 2 additional doses of Trelegy: 100/31.25/25mcg and 200/31.25/25mcg; increases in trough FEV ...
Nebulized Anticholinergic Therapy for Maintenance Treatment of …
Revefenacin. Tiotropium. Umeclidinium. For select patients with COPD, nebulized drugs might offer an alternative to a breath-actuated, hand-held inhaler. 5 Adherence to inhaled medication in patients with COPD is low, with the nonadherence rate ranging from 50% to 80%. 6 Among the causes of nonadherence is the inability to use an inhaler as ...
Restrictive Lung Diseases | Diagnosis & Disease Information
May 29, 2024 · Restrictive lung diseases are respiratory disorders marked by diminished lung capacity stemming from a wide range of underlying factors, including changes in lung parenchyma or conditions that affect the pleura, chest wall, or neuromuscular system. 1 Restrictive lung diseases can be classified as pulmonary parenchyma diseases (intrinsic causes) or extrapulmonary diseases (extrinsic causes ...
Flying With COPD: Expert Advice - Pulmonology Advisor
Nov 30, 2018 · Dr Khabbaza: Air travel subjects patients with COPD to lower oxygen pressures in the cabin, which is similar to breathing about 15% oxygen at sea level. 1 Patients with COPD have a lower respiratory reserve and are at a higher risk of developing hypoxemia during air travel. Additionally, patients with chronic hypoxemia requiring continuous ...
Diagnosis & Disease Information - Pulmonology Advisor
January 23, 2024. Thoracentesis, also known as a pleural tap, is a procedure performed to remove fluid or air from the pleural space surrounding the lungs. 1 A minimally invasive procedure, thoracentesis is used to obtain a fluid sample for diagnosing and/or treating various health conditions, including pleural effusions, cancer, and ...
Updated CHEST Guidelines on Antithrombotic Therapy in Venous ...
Jan 21, 2022 · The updated CHEST guideline on antithrombotic therapy for VTE includes 4 new PICO questions as well as updated recommendations based on newer evidence. Updates to the American College of Chest Physicians (CHEST) clinical practice guideline on antithrombotic therapy in venous thromboembolism (VTE) include recommendations on several Population ...
Montelukast Plus Levocetirizine vs Monotherapy in Asthma, …
Oct 8, 2018 · SAN ANTONIO — A fixed-dose combination of montelukast plus levocetirizine was safe and effective for the treatment of perennial allergic rhinitis and asthma compared with montelukast alone, according to research presented at the CHEST Annual Meeting, held October 6 through October 10 in San Antonio, Texas. A 4-week double-blind, randomized ...